Furosemide: Potent Loop Diuretic for Effective Fluid Management
Furosemide
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.77 | $46.00 (0%) | 🛒 Add to cart |
| 90 | $0.67 | $69.00 $60.00 (13%) | 🛒 Add to cart |
| 120 | $0.62 | $92.00 $75.00 (18%) | 🛒 Add to cart |
| 180 | $0.58 | $138.00 $105.00 (24%) | 🛒 Add to cart |
| 270 | $0.56 | $207.00 $150.00 (28%) | 🛒 Add to cart |
| 360 | $0.54
Best per pill | $276.00 $193.00 (30%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.36 | $65.00 (0%) | 🛒 Add to cart |
| 270 | $0.35 | $97.50 $94.00 (4%) | 🛒 Add to cart |
| 360 | $0.34
Best per pill | $130.00 $121.00 (7%) | 🛒 Add to cart |
Synonyms | |||
Furosemide is a high-ceiling loop diuretic indicated for the management of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. It acts on the ascending limb of the loop of Henle to inhibit the reabsorption of sodium and chloride, producing a profound diuresis. This agent is particularly valuable in cases where other diuretics prove insufficient, offering a rapid onset of action suitable for both chronic maintenance and acute pulmonary edema. Its efficacy in reducing extracellular fluid volume makes it a cornerstone therapy in cardiovascular and renal medicine.
Features
- Active Ingredient: Furosemide
- Pharmacologic Class: Loop diuretic
- Available Formulations: Oral tablets (20 mg, 40 mg, 80 mg), intravenous solution (10 mg/mL)
- Onset of Action: Oral: 30-60 minutes; IV: within 5 minutes
- Peak Effect: Oral: 1-2 hours; IV: 30 minutes
- Duration of Action: 6-8 hours
- Bioavailability: Approximately 60-70% (oral)
- Protein Binding: >98%
- Metabolism: Hepatic (minimal)
- Elimination Half-life: Approximately 2 hours
- Excretion: Primarily renal (unchanged drug and metabolites)
Benefits
- Rapid and significant reduction of edema in peripheral tissues and pulmonary vasculature, alleviating symptoms of dyspnea and discomfort.
- Effective management of hypertension through reduction in plasma and extracellular fluid volume, often used adjunctively with other antihypertensive agents.
- Prevention of fluid overload in patients with compromised cardiac or renal function, reducing hospitalizations and improving quality of life.
- Utility in acute settings such as hypertensive crises or acute pulmonary edema due to its prompt IV diuretic effect.
- Dose-dependent response allows for tailored therapy based on individual patient needs and clinical response.
- Established safety profile with decades of clinical use and extensive research supporting its efficacy in indicated conditions.
Common use
Furosemide is primarily employed in the treatment of edema resulting from congestive heart failure, liver cirrhosis, and renal impairment, including chronic kidney disease. It is also utilized off-label for hypercalcemia and in conjunction with saline for forced diuresis in certain toxic ingestions. In cardiology, it is a first-line agent for acute decompensated heart failure. Nephrologists may use it to manage volume overload in dialysis patients or those with resistant edema. Its role in hypertension is generally reserved for cases with concomitant fluid retention or when thiazide diuretics are inadequate.
Dosage and direction
Dosage must be individualized based on patient response and clinical condition. For adults with edema, the usual initial oral dose is 20 to 80 mg given as a single dose, which may be increased by 20 to 40 mg no sooner than 6 to 8 hours after the previous dose until the desired diuretic effect is achieved. The maintenance dose may be given once or twice daily (e.g., morning and early afternoon). For intravenous administration in hospitalized patients, the initial dose is 20 to 40 mg, injected slowly over 1 to 2 minutes; if response is inadequate, may increase dose by 20 mg no sooner than 2 hours after previous dose. For hypertension, oral doses typically range from 40 mg twice daily initially, adjusted according to response. Doses exceeding 600 mg/day are not recommended. Administer with food or milk to minimize gastrointestinal upset. Monitor electrolytes and renal function periodically.
Precautions
Monitor blood pressure, renal function, and serum electrolytes (particularly potassium, sodium, chloride, magnesium, and calcium) at baseline and periodically during therapy. Risk of hypokalemia is significant; consider potassium supplementation or potassium-sparing diuretic if necessary. Ototoxicity (usually reversible) may occur, especially with rapid IV injection, high doses, or concurrent use of other ototoxic drugs. Use with caution in patients with sulfonamide allergy (cross-reactivity possible). Photosensitivity reactions may occur; advise sun protection. May precipitate gout in susceptible individuals. Cirrhotic patients are at increased risk of electrolyte imbalance and hepatic encephalopathy; initiate therapy in hospital setting if possible. Elderly patients may be more sensitive to effects.
Contraindications
Anuria; hypersensitivity to furosemide or any component of the formulation; patients with hepatic coma or severe electrolyte depletion until condition improves or is corrected. Not recommended in infants.
Possible side effect
Common: dizziness, headache, orthostatic hypotension, hyperglycemia, increased serum creatinine, electrolyte depletion (hypokalemia, hyponatremia, hypochloremia, hypocalcemia, hypomagnesemia), hyperuricemia. Less common: ototoxicity (tinnitus, hearing loss), photosensitivity, rash, pancreatitis, blood dyscrasias (thrombocytopenia, agranulocytosis, aplastic anemia), interstitial nephritis. Gastrointestinal effects: nausea, vomiting, diarrhea, constipation. Rare: Stevens-Johnson syndrome, toxic epidermal necrolysis.
Drug interaction
Aminoglycosides, cisplatin: Increased risk of ototoxicity and nephrotoxicity.
Digoxin: Hypokalemia may increase risk of digoxin toxicity.
Lithium: Reduced renal clearance of lithium; increased lithium levels and toxicity.
NSAIDs: May reduce diuretic and antihypertensive effect; increased risk of renal impairment.
Probenecid: Reduces diuretic effect of furosemide.
Sucralfate: May reduce absorption of furosemide; separate administration by at least 2 hours.
Antihypertensives, nitrates: Additive hypotensive effect.
Corticosteroids, amphotericin B: Enhanced potassium wasting.
Salicylates: Increased risk of salicylate toxicity at lower doses.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for the missed one. Resume the regular dosing schedule. For once-daily dosing, if missed, take when remembered unless next dose is due within 8 hours. For twice-daily dosing, if missed, take when remembered unless within 4 hours of next dose.
Overdose
Symptoms include profound water loss, electrolyte depletion (manifested by weakness, dizziness, confusion, anorexia, vomiting, cramps), dehydration, reduction in blood volume, circulatory collapse (with possibility of vascular thrombosis and embolism). Treatment is supportive and symptomatic; replace fluid and electrolytes as needed. There is no specific antidote. Hemodialysis does not accelerate elimination.
Storage
Store at controlled room temperature (20°C to 25°C or 68°F to 77°F). Protect from light and moisture. Keep in original container, tightly closed. Do not freeze. Keep out of reach of children and pets. Discard any unused medication after the expiration date.
Disclaimer
This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions regarding a medical condition or before starting any new treatment. Do not disregard professional medical advice or delay seeking it because of something you have read here. The efficacy and safety of furosemide should be evaluated by a physician based on individual patient factors.
Reviews
“Furosemide remains an indispensable tool in managing decompensated heart failure. Its rapid onset and predictable efficacy in reducing preload make it a first-line agent in acute settings. However, vigilant monitoring of electrolytes is paramount to avoid complications.” – Cardiologist, 15 years experience.
“In renal patients, furosemide can be effective, but its utility diminishes with declining GFR. We often use higher doses and sometimes combine with thiazides for synergistic effect in resistant edema. Ototoxicity is a concern with high-dose or IV use.” – Nephrologist, 10 years experience.
“As a hospitalist, I rely on IV furosemide for rapid diuresis in pulmonary edema. The key is careful dosing and monitoring urine output. Be cautious in elderly patients due to risk of dehydration and electrolyte shifts.” – Internal Medicine Physician, 8 years experience.
“While effective, furosemide requires careful patient education regarding timing of doses (to avoid nocturia) and signs of hypokalemia. In long-term use, we often need to supplement potassium or use a potassium-sparing agent.” – Clinical Pharmacist, 12 years experience.